Active Ingredient: CANAGLIFLOZIN
Proprietary Name: INVOKANA
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 300MG
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code:
Application Number: N204042
Product Number: 002
Approval Date: Mar 29, 2013
Applicant Holder Full Name: JANSSEN PHARMACEUTICALS INC
Marketing Status:
Prescription
Patent and Exclusivity Information
